—
C+
C+ The full Closelook — membership. Open the C+ overview

Becton Dickinson and Company (BDX) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Becton Dickinson and Company

BDX in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Becton Dickinson supplies medical devices, lab instruments and diagnostic tools to hospitals, physicians, researchers and pharmaceutical firms worldwide. Its operations split into five segments — Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences — covering IV catheters, syringes, drug-delivery systems, blood-collection tubes, molecular diagnostics and cell-sorting instruments. It also makes hernia-repair and biosurgery products. The firm is based in Franklin Lakes, New Jersey, and sells to clinical laboratories and healthcare institutions across the world.
Where it sits in the stack
Becton Dickinson holds no seat in Rubin, our AI build-out index, so it sits outside that stack. It belongs instead to the healthcare and medical-instruments sector of the wider universe the diary tracks, alongside diagnostics and life-science tool makers.
Who it is priced against
Closelook's peer group for BDX has not been built. The comparison the market draws is with Danaher, another diversified life-science and diagnostics maker.
Why Closelook tracks it
BDX holds a seat in the S&P 500, one of the index families the diary follows. It does not yet carry a Closelook score. It appeared in a Midday 10 edition, named within Barchart's large-cap 52-week high list alongside other health-care and biotech names.
What the diary watches
The diary watches whether the broader move into health-care and biotech names, visible in that breadth list, continues or fades as attention shifts away from technology.

Becton Dickinson and Company (BDX) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for BDX, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 1 analyst action on the wire · latest: price target by RBC Capital, 2026-08-13

The Street on this name

Analyst actions and the latest print for BDX from the Closelook wires — third-party opinions on the record, not our readings.

  • Price target RBC Capital — target 190 from 180 Target raised to $190 from $180 (+3.2% to spot) 2026-08-13

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

Who it is priced against Medical Instruments & Supplies · United States · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against BDX on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 2.32%, quarterly · last 1.05 USD on 2026-09-09

Dividends and capital return

What BDX pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 4.20 USD per share · a 2.32% yield on the 2026-09-18 close 4 distributions, paid quarterly 2026-09-18
  • Change on the year +1.0% against the prior twelve months prior twelve months 4.16 USD per share
  • Last distribution 1.05 USD per share as the price series records it, within days of the ex-date 2026-09-09
  • By calendar year 2023: 0.95 USD (partial) · 2024: 3.89 USD · 2025: 4.17 USD · 2026: 3.15 USD to date first distribution recorded in the three-year window: 2023-12-07

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is Becton Dickinson and Company (BDX)?

Becton Dickinson and Company trades as BDX on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-19.

Is BDX in a Closelook index?

Not currently — Becton Dickinson and Company is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

Where does BDX trade against its moving averages?

Uptrend stack intact: Trades +3.6% vs the 50-day and +12.6% vs the 200-day average, 6.3% below the 52-week high and +43.5% off the 52-week low; a golden cross printed 28 sessions ago. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Becton Dickinson and Company do?

Becton Dickinson supplies medical devices, lab instruments and diagnostic tools to hospitals, physicians, researchers and pharmaceutical firms worldwide. Its operations split into five segments — Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences — covering IV catheters, syringes, drug-delivery systems, blood-collection tubes, molecular diagnostics and cell-sorting instruments. It also makes hernia-repair and biosurgery products. Closelook's peer group for BDX has not been built. The comparison the market draws is with Danaher, another diversified life-science and diagnostics maker.

Where does Becton Dickinson and Company sit in the AI build-out?

Becton Dickinson holds no seat in Rubin, our AI build-out index, so it sits outside that stack. It belongs instead to the healthcare and medical-instruments sector of the wider universe the diary tracks, alongside diagnostics and life-science tool makers. BDX holds a seat in the S&P 500, one of the index families the diary follows. It does not yet carry a Closelook score. It appeared in a Midday 10 edition, named within Barchart's large-cap 52-week high list alongside other health-care and biotech names.

Does Becton Dickinson and Company pay a dividend?

Becton Dickinson and Company has paid 4.20 USD per share over the last twelve months, paid quarterly, a trailing yield of 2.32% on the 2026-09-18 close; the last distribution recorded in the price series was 1.05 USD on 2026-09-09. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Becton Dickinson and Company recently?

The most recent analyst action on Becton Dickinson and Company on the Closelook wire is a price target by RBC Capital on 2026-08-13 (target 190 from 180). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelook readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

Where has Closelook written about Becton Dickinson and Company?

Becton Dickinson and Company appears in 1 Closelook piece, most recently Midday 10: A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000 (2026-08-21). What Closelook said most recently: Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG… (Midday 10, 2026-08-21). The "Mentioned on Closelook" block on this page lists the long reads, the reference entries and the dailies that name it.

What does this page show?

A live price chart with SMA overlays and drawing tools for BDX, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Mentioned on Closelook 1 piece · newest: Midday 10, “A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000” (2026-08-21)

Mentioned on Closelook

Where BDX appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Related in the Closelook universe

then Medical Instruments & Supplies. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.